Meeting
2022 ASCO Annual Meeting
Prognostic significance of the CP-GEP assay combining clinicopathologic factors and gene expression profiling in patients (pts) with AJCC v8 stage I/II cutaneous melanoma (CM).
Authors
Teresa Maria Santos Amaral
Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany
Teresa Maria Santos Amaral , Tobias Sinnberg , Eftychia Chatziioannou , Heike Niessner , Ulrike M. Leiter , Ulrike Keim , Andrea Forschner , Jvalini Dwarkasing , Lisette Meerstein-Kessel , Thomas Rademaker , Renske Wever , Alexander M. Eggermont , Lukas Flatz , Stephan Forchhammer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9564)
DOI
10.1200/JCO.2022.40.16_suppl.9564
Abstract #
9564
Poster Bd #
157
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).
First Author: David H. Lawson
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic factors of gallbladder cancer (GBC) in patients diagnosed over a period of 20 years: A Canadian province experience.
First Author: Nima Hamidi Toussi
Poster
2023 ASCO Annual Meeting
The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery.
First Author: JEONGSEOK JEON
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The prognostic value of C-reactive protein/albumin ratio and platelet-lymphocyte ratio in patients with pancreatic cancer.
First Author: Yang-Chen Shen